Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Current Treatment approach to a mild to moderate atopic dermatitis patient.
For patients with mild to moderate atopic dermatitis, the primary treatment approach focuses on moisturizing the skin. Regular use of emollients helps to restore the skin barrier, reducing dryness and irritation. Patients are encouraged to apply these moisturizers multiple times a day, especially after bathing.
Topical corticosteroids are commonly prescribed to manage inflammation and itching. These medications come in various strengths, allowing healthcare providers to tailor treatment based on the severity of the symptoms. Patients should apply the corticosteroids as directed, typically once or twice daily, for the best results.
In addition to corticosteroids, calcineurin inhibitors like tacrolimus or pimecrolimus can be used as an alternative treatment. These medications help reduce inflammation without the side effects associated with long-term steroid use. They are particularly useful for sensitive areas, such as the face and neck.
Therefore, get an overall knowledge of the current Treatment approach to a mild to moderate atopic dermatitis patient. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Why preventive mastectomy isn't offered to everyone at risk
2.
Financial hardship common in patients with cancer
3.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.
4.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
5.
Severe obesity associated with reduced prevalence of recommended cancer screenings
1.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
2.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells
5.
Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation